These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10859047)

  • 1. Factor XIII-mediated inhibition of fibrinolysis and venous leg ulcers.
    Herouy Y; Hellstern MO; Vanscheidt W; Schöpf E; Norgauer J
    Lancet; 2000 Jun; 355(9219):1970-1. PubMed ID: 10859047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XIII in ulcerative leg disease: background and preliminary clinical results.
    Wozniak G; Dapper F; Alemany J
    Semin Thromb Hemost; 1996; 22(5):445-50. PubMed ID: 8989829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on zinc in wound healing.
    Agren MS
    Acta Derm Venereol Suppl (Stockh); 1990; 154():1-36. PubMed ID: 2275309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of coagulation factor XIII in the pathogenesis of venous leg ulcers.
    Peschen M; Thimm C; Weyl A; Weiss JM; Kurz H; Augustin M; Simon JC; Schöpf E; Vanscheidt W
    Vasa; 1998 May; 27(2):89-93. PubMed ID: 9612112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of a novel gel dressing in the management of neuropathic leg ulcers in diabetic patients: a prospective double-blind randomized trial.
    Abbruzzese L; Rizzo L; Fanelli G; Tedeschi A; Scatena A; Goretti C; Macchiarini S; Piaggesi A
    Int J Low Extrem Wounds; 2009 Sep; 8(3):134-40. PubMed ID: 19703948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XIII-deficiency in the blood of venous leg ulcer patients.
    Vanscheidt W; Hasler K; Wokalek H; Niedner R; Schöpf E
    Acta Derm Venereol; 1991; 71(1):55-7. PubMed ID: 1676216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wound healing and fibrinolytic activity.
    Szekeres L; Török L; Simon N
    Vasa; 1973; 2(1):81-3. PubMed ID: 4708265
    [No Abstract]   [Full Text] [Related]  

  • 8. Healing effect of ketanserin on chronic leg ulcers in patients with diabetes.
    Quatresooz P; Kharfi M; Paquet P; Vroome V; Cauwenbergh G; Piérard GE
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):277-81. PubMed ID: 16503887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of mesoglycan topical treatment of leg ulcers in subjects with chronic venous insufficiency].
    La Marca G; Pumilia G; Martino A
    Minerva Cardioangiol; 1999 Sep; 47(9):315-9. PubMed ID: 10630070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leg ulcers treated with topical tacrolimus in patients with rheumatoid arthritis.
    Mandelin J; Eklund KK; Reitamo S
    Acta Derm Venereol; 2010 Nov; 90(6):633-4. PubMed ID: 21057750
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of hyaluronic acid in treatment of leg ulcers: a double-blind RCT.
    Dereure O; Czubek M; Combemale P
    J Wound Care; 2012 Mar; 21(3):131-2, 134-6, 138-9. PubMed ID: 22399081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogenic bovine whey extract modulates matrix metalloproteinase-2, -9, and tissue inhibitor of matrix metalloproteinase-2 levels in chronic leg ulcers.
    Varelias A; Cowin AJ; Adams D; Harries RH; Cooter RD; Belford DA; Fitridge RA; Rayner TE
    Wound Repair Regen; 2006; 14(1):28-37. PubMed ID: 16476069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Zinc in the treatment of crural ulcers].
    Rubisz-Brzezińska J; Kralewska W; Brzezińska-Wcisło L
    Przegl Dermatol; 1980; 67(1):73-9. PubMed ID: 7375656
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical zinc oxide treatment improves arterial and venous leg ulcers.
    Strömberg HE; Agren MS
    Br J Dermatol; 1984 Oct; 111(4):461-8. PubMed ID: 6386033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical effectiveness of molgramostim (GM-CSF) in sickle cell leg ulcers.
    Méry L; Girot R; Aractingi S
    Dermatology; 2004; 208(2):135-7. PubMed ID: 15057003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local treatment of venous ulcers with tissue type plasminogen activator containing ointment.
    Zeegelaar JE; Verheijen JH; Kerckhaert JA; Jankowski I; Faber WR
    Vasa; 1997 May; 26(2):81-4. PubMed ID: 9174382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report.
    Krupski WC; Reilly LM; Perez S; Moss KM; Crombleholme PA; Rapp JH
    J Vasc Surg; 1991 Oct; 14(4):526-32; discussion 532-6. PubMed ID: 1920650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trental forte in leg ulcer therapy. Result of a field study].
    Weitgasser H; Schmidt-Modrow G
    Z Hautkr; 1982 Nov; 57(21):1574-80. PubMed ID: 7148072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical application of the tumour necrosis factor-alpha antibody infliximab improves healing of chronic wounds.
    Streit M; Beleznay Z; Braathen LR
    Int Wound J; 2006 Sep; 3(3):171-9. PubMed ID: 16984574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catrix: an easy-to-use collagen treatment for wound healing.
    King S
    Br J Community Nurs; 2005 Sep; 10(9):S31-4. PubMed ID: 16245393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.